High Outlier
OTC
Strength
650; 20; 10 mg/30mL; mg/30mL; mg/30mL
Manufacturer
Haleon US Holdings LLCNDC
00067812708
Classification
Brand
Dosage Form
SYRUP
Route
ORAL
Last Updated
1/22/2020
Approval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/15/2015
Pharmacological Classes
Adrenergic alpha1-Agonists
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
THERAFLU EXPRESSMAX COLD NT LQ
Brand
00067812908•Haleon US Holdings LLC
$0.0221
per ML
VICKS NYQUIL SEVERE COLD-FLU
Brand
37000081212•The Procter & Gamble Manufacturing Company
$0.0235
per ML
VICKS NYQUIL SEVERE COLD-FLU
Brand
37000081512•The Procter & Gamble Manufacturing Company
$0.0235
per ML
ADT ROBITUSSIN PEAK CLD M-S LQ
Brand
00031874220•Haleon US Holdings LLC
$0.0284
per ML
VICKS NYQUIL SEVERE COLD-FLU
Brand
37000081208•The Procter & Gamble Manufacturing Company
$0.0293
per ML
VICKS NYQUIL SEVERE COLD-FLU
Brand
37000081508•The Procter & Gamble Manufacturing Company
$0.0293
per ML
VICKS DAYQUIL SEVERE COLD-FLU
Brand
37000081008•The Procter & Gamble Manufacturing Company
$0.0303
per ML
ADT ROBITUSSIN PEAK CLD M-S LQ
Brand
00031874214•Haleon US Holdings LLC
$0.0368
per ML
ROBITUSSIN COUGH-COLD CF LIQ
Brand
00031871612•Haleon US Holdings LLC
$0.0372
per ML
ROBITUSSIN LONG-ACTING LIQ
Brand
00031869312•Haleon US Holdings LLC
$0.0375
per ML